Powder-layered oral dosage forms

Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Capsules

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424458, 424490, 424493, 427 214, A61K 962

Patent

active

060775335

ABSTRACT:
An oral dosage form of morphine is formulated by powder-layering an homogeneous mixture of morphine sulfate and hydrous lactose impalpable onto inert beads to obtain a multiparticulate product. A plurality of the powder-layered beads may be administered either in immediate release form or in an extended release form by coating with a hydrophobic material. In addition, multi-particulate oral dosage forms containing therapeutically effective agents containing a plurality of pharmaceutically acceptable inert beads powder-layered with homogeneous mixture of a therapeutically effective agent and hydrous lactose impalpable are also disclosed. A method of preparing the dosage forms as well as a method preparing spheroids containing the homogeneous mixture of therapeutically effective agent and hydrous lactose impalpable are also disclosed.

REFERENCES:
patent: 2738303 (1956-03-01), Blythe
patent: 3639170 (1972-02-01), Hutton et al.
patent: 3845770 (1974-11-01), Theeuwes et al.
patent: 3916889 (1975-11-01), Russell
patent: 4063064 (1977-12-01), Saunders et al.
patent: 4088864 (1978-05-01), Theeuwes et al.
patent: 4213977 (1980-07-01), Schane, Jr. et al.
patent: 4828840 (1989-05-01), Sakamoto et al.
patent: 5026560 (1991-06-01), Makino et al.
patent: 5132142 (1992-07-01), Jones et al.
patent: 5133974 (1992-07-01), Paradissis et al.
patent: 5167964 (1992-12-01), Muhammad et al.
patent: 5202128 (1993-04-01), Morella et al.
patent: 5260072 (1993-11-01), Roche et al.
patent: 5382434 (1995-01-01), de Haan et al.
patent: 5384130 (1995-01-01), Kamada
patent: 5395627 (1995-03-01), Dopper et al.
patent: 5401502 (1995-03-01), Wunderlich et al.
patent: 5405616 (1995-04-01), Wunderlich et al.
patent: 5411745 (1995-05-01), Oshlack et al.
patent: 5478577 (1995-12-01), Sackler et al.
patent: 5527543 (1996-06-01), Dopper et al.
patent: 5574150 (1996-11-01), Yaginuma et al.
patent: 5662936 (1997-09-01), Haan et al.
patent: 5672360 (1997-09-01), Sackler et al.
Kaiko, et al. "A single-dose study of the effect of food ingestion and timing of dose administration on the pharmacokinetic profile of 30 mg sustained-release morphine sulfate tablets", Current Therapeutic Research, pp. 869-878, vol. 47, No. 5, May 1990.
Kaiko, et al. "Controlled-release morphine bioavailability (MS Contin.RTM. tablets) in the presence and absence of food" The Hospice Journal, pp. 17-30, vol. 6(4), 1990.
Gourlay, et al. "the reproducibility of bioavailability of oral morphine from solution under fed and fasted conditions", Journal of Pain and Symptom Management, pp. 431-436, vol. 6, No. 7, Oct. 1991.
Gourlay, et al., "Influence of a high-fat meal on the absorption of morphine from oral solutions", Clin Pharmacol Ther, pp. 403-468, Oct. 1989.
MSIR.RTM. Package Insert, The Purdue Frederick Company, Feb. 11, 1993 (F3154).
MSIR.RTM. Capsules Prescribing Information Booklet, The Purdue Frederick Company, Feb. 11, 1993(PR101/L149).
MSIR.RTM., Product Information Pamphlet (PR 104/L131), The Purdue Frederick Company, Copyright 1993, which includes the following documents: PR108/L233; PR107/L232; and PR100B/L123.
The Merck Index, 11th Edition, Susan Budavari, Editor, Published by Merck & Co., Inc., Rahway, N.J., p. 5224, 1989.
Martindale, The Extra Pharmacopoeia, 25th Edition, p. 54, Edited by James E.F. Reynolds, published by the Pharmaceutical Press, London, 1982.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Powder-layered oral dosage forms does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Powder-layered oral dosage forms, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Powder-layered oral dosage forms will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1850004

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.